PIER 88 INVESTMENT PARTNERS LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
PIER 88 INVESTMENT PARTNERS LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$416,392
-61.3%
11,680
-49.9%
0.10%
-60.9%
Q2 2023$1,074,829
+23.2%
23,300
+7.1%
0.27%
+26.1%
Q1 2023$872,175
-13.4%
21,7500.0%0.21%
-13.5%
Q4 2022$1,007,678
+6.5%
21,750
-4.8%
0.24%
+8.4%
Q3 2022$946,000
+1.9%
22,840
+46.9%
0.22%
+3.2%
Q2 2022$928,000
-17.8%
15,5500.0%0.22%
-46.2%
Q1 2022$1,129,000
-13.7%
15,5500.0%0.40%
+45.7%
Q4 2021$1,308,000
+20.0%
15,550
+28.6%
0.28%
-15.0%
Q3 2021$1,090,000
+62.0%
12,090
+71.1%
0.33%
+69.4%
Q2 2021$673,000
+2.6%
7,065
+22.5%
0.19%
-13.5%
Q1 2021$656,000
+42.9%
5,765
+73.6%
0.22%
+50.7%
Q4 2020$459,000
-51.2%
3,320
-71.0%
0.15%
-48.1%
Q3 2020$941,000
-27.2%
11,450
-30.7%
0.28%
-22.3%
Q2 2020$1,292,000
+98.2%
16,515
+12.6%
0.37%
+54.2%
Q1 2020$652,000
+4.2%
14,6650.0%0.24%
-4.0%
Q4 2019$626,000
+13.2%
14,665
+13.5%
0.25%
+15.9%
Q3 2019$553,000
-16.0%
12,925
+24.7%
0.21%
-23.3%
Q2 2019$658,000
-8.5%
10,3650.0%0.28%
-15.7%
Q1 2019$719,000
+126.1%
10,365
+41.7%
0.33%
+105.6%
Q4 2018$318,000
-40.9%
7,315
+3.8%
0.16%
-31.2%
Q3 2018$538,000
+20.6%
7,045
+21.5%
0.23%
+11.4%
Q2 2018$446,0005,8000.21%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders